🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objectives: * To determine the maximum tolerated dose (MTD) of Top...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-08
Trial ID
NCT00502892
Treatments Being Tested
This research is being done to assess the effectiveness and safety of the c...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-02-14
Trial ID
NCT04119336
Treatments Being Tested
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00157196
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
The purpose of this study is to determine the safety and effectiveness of U...
Status
Completed
Location
Texas Children's Hospital
Start Date
2009-09
Trial ID
NCT00950846
Treatments Being Tested
Primary objective of the study is to compare the efficacy of romidepsin whe...
Status
Completed
Location
ZNA Stuivenberg
Start Date
2013-01
Trial ID
NCT01796002
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867